VEGFA and neoplasm: Future research should focus on optimizing dosing strategies to maximize efficacy while minimizing toxicity, understanding biomarkers predictive of response to VEGF-targeted immunotherapy combinations, and elucidating the mechanisms by which VEGF inhibition remodels the tumor immune milieu.